GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » VentriPoint Diagnostics Ltd (TSXV:VPT) » Definitions » Gross-Profit-to-Asset %

VentriPoint Diagnostics (TSXV:VPT) Gross-Profit-to-Asset % : 6.83% (As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is VentriPoint Diagnostics Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. VentriPoint Diagnostics's annualized Gross Profit for the quarter that ended in Dec. 2023 was C$0.16 Mil. VentriPoint Diagnostics's average Total Assets over the quarter that ended in Dec. 2023 was C$2.40 Mil. Therefore, VentriPoint Diagnostics's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 6.83%.


VentriPoint Diagnostics Gross-Profit-to-Asset % Historical Data

The historical data trend for VentriPoint Diagnostics's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VentriPoint Diagnostics Gross-Profit-to-Asset % Chart

VentriPoint Diagnostics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.49 4.66 - 0.75 1.07

VentriPoint Diagnostics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.41 0.30 0.37 -0.82 6.83

Competitive Comparison of VentriPoint Diagnostics's Gross-Profit-to-Asset %

For the Medical Devices subindustry, VentriPoint Diagnostics's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


VentriPoint Diagnostics's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, VentriPoint Diagnostics's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where VentriPoint Diagnostics's Gross-Profit-to-Asset % falls into.



VentriPoint Diagnostics Gross-Profit-to-Asset % Calculation

VentriPoint Diagnostics's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=0.042/( (5.977+1.883)/ 2 )
=0.042/3.93
=1.07 %

VentriPoint Diagnostics's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=0.164/( (2.916+1.883)/ 2 )
=0.164/2.3995
=6.83 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


VentriPoint Diagnostics Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of VentriPoint Diagnostics's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


VentriPoint Diagnostics (TSXV:VPT) Business Description

Traded in Other Exchanges
Address
18 Hook Avenue, Unit 101, Toronto, ON, CAN, M6P 1T4
VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It develops applications for heart diseases and imaging modalities which includes congenital heart disease, left or right heart failure, and normal hearts. It sells its products in Canada and internationally.
Executives
Robert Hodgkinson Director

VentriPoint Diagnostics (TSXV:VPT) Headlines

No Headlines